1. Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
    Jinyan Zhang et al, 2018, BioMed Research International CrossRef
  2. Glycosylation and Liver Cancer
    Anand Mehta et al, 2015, Glycosylation and Cancer CrossRef
  3. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ
    Yuanyuan Zhang et al, 2020, Disease Markers CrossRef
  4. Extract from mistletoe, Viscum album L., reduces Hsp27 and 14-3-3 protein expression and induces apoptosis in C6 rat glioma cells
    E.Ö. Uçar et al, 2012, Genetics and Molecular Research CrossRef
  5. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression
    Yan Li et al, 2017, International Journal of Oncology CrossRef
  6. Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice
    Zhuona Rong et al, 2017, Molecular & Cellular Proteomics CrossRef
  7. Oxidative stress response induced by chemotherapy in leukemia treatment (Review)
    Jin Zhang et al, 2018, Molecular and Clinical Oncology CrossRef
  8. Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model
    Kian Chuan Sia et al, 2013, Molecular Cancer Therapeutics CrossRef
  9. Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test
    Devalingam Mahalingam et al, 2021, Cancers CrossRef
  10. HNF4A as a potential target of PFOA and PFOS leading to hepatic steatosis: Integrated molecular docking, molecular dynamic and transcriptomic analyses
    Rui Li et al, 2024, Chemico-Biological Interactions CrossRef
  11. Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma
    Lei-Miao Yin et al, 2019, Trends in Biochemical Sciences CrossRef
  12. Decreased expression of glutathione S‐transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma
    Hai‐long Ma et al, 2015, Journal of Oral Pathology & Medicine CrossRef
  13. Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
    Yi-Ju Wu et al, 2015, Cancers CrossRef
  14. Effect and mechanism of action in vitro of cyclodextrin derivative nanoparticles loaded with tyroserleutide on hepatoma
    Xiaoyan Wu et al, 2021, Nanotechnology CrossRef
  15. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors
    Henning Reis et al, 2015, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  16. iTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure
    LIANG PENG et al, 2015, Experimental and Therapeutic Medicine CrossRef
  17. TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication
    Youjia Yu et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  18. Alpha 1 Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
    Aleksandra Topic et al, 2012, Hepatitis Monthly CrossRef
  19. Circadian Rhythm Connections to Oxidative Stress: Implications for Human Health
    Melissa Wilking et al, 2013, Antioxidants & Redox Signaling CrossRef
  20. Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling
    Rong Li et al, 2024, Cancer Letters CrossRef
  21. Early changes in the urine proteome in a rat liver tumour model
    Yameng Zhang et al, 2020, PeerJ CrossRef